NEPTUNUS(SZ:000078) Zheng Xing Xing Ye Ri Bao·2025-12-01 09:09Market Performance - The pharmaceutical commercial sector increased by 0.96% on December 1, with Haiwang Biological leading the gains [1] - The Shanghai Composite Index closed at 3914.01, up 0.65%, while the Shenzhen Component Index closed at 13146.72, up 1.25% [1] Individual Stock Performance - Haiwang Biological (code: 000078) saw a significant rise of 10.00%, closing at 3.74 with a trading volume of 5.34 million shares [1] - Other notable gainers included Jiashitang (code: 002462) with a 3.73% increase, Daclin (code: 603233) up 3.45%, and Kaikai Industrial (code: 600272) rising by 3.05% [1] Capital Flow Analysis - The pharmaceutical commercial sector experienced a net outflow of 255 million yuan from institutional investors, while retail investors saw a net inflow of 272 million yuan [2] - The overall capital flow indicates a mixed sentiment, with institutional investors withdrawing funds while retail investors increased their positions [2] Detailed Capital Flow for Selected Stocks - Shanghai Pharmaceuticals (code: 601607) had a net inflow of 36.87 million yuan from institutional investors, while it faced a net outflow of 31.01 million yuan from retail investors [3] - Yifeng Pharmacy (code: 603939) showed a net inflow of 14.39 million yuan from institutional investors, indicating positive sentiment despite overall sector outflows [3]